Chenchao Liu

Digital Health Asia – The Future Transformation
Tuesday | April 24 | 09:30 - 13:00
ESMT

Chenchao Liu is the founder and managing partner of Silreal, a consulting firm focusing on healthcare that enables innovation exchange and investments between Europe and China. As an entrepreneur with a foundation in chemistry and health policy, Chenchao has both a broad and extensive network in the healthcare industry. He has helped several health-focused companies find strategic partners in China and Germany, starting from market entry and identifying their first hire to regulatory consulting and clients sourcing. Chenchao has been in Germany for more than 16 years and has restructured some major hospitals in Germany as well as conducting research in the Max-Planck Institute of Quantum Optics, he then became respected alumnus to give career advice to scientists. Chenchao is co-founder and managing partner at DH Bioinvest Ltd., an AI-driven investment platform that connects innovative European health companies with investors in China. Capitalising his extensive insights about China and its interrelations with Europe, Chenchao combines his expertise in healthcare and his intercultural competencies to enable funds and financial institutions to place strategic investments into cutting-edge healthcare technology firms along the Belt and Road Initiative with focus on Germany. He is regularly invited as guest and speaker at various international conferences: e.g. B20 Conference, Munich Security Conference, British German Forum, Asian Financial Forum, Horasis China Meeting and China Foreign Experts Affairs. Mr. Liu was interviewed by The New York Times.